Beta Bionics’ Insulin Patch Pump Gets FDA Nod

Beta Bionics’ insulin patch pump gets FDA nod

By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.

Beta Bionics insulin patch pump scores FDA clearance

Beta Bionics (NASDAQ: BBNX) has claimed an FDA clearance for its first patch pump insulin delivery system, amid plans to roll out an updated diabetes dosing algorithm and the launch of a new CGM partnership with Senseonics. The three-day, wearable Mint carries a 200-unit insulin reservoir as well as a combination of reusable and disposable […]

FDA Clears Beta Bionics’ Mint Patch Pump - Orange County Business Journal

Beta Bionics Inc., an Irvine-based maker of automated insulin delivery systems for diabetes, received FDA clearance for its Mint patch pump. The company also submitted a 510(k) application for a next-generation insulin dosing algorithm. Beta expects to begin commercializing Mint in the U.S. in the first quarter of 2027. The company additionally lowered its full-year revenue guidance to $121 million to $126 million from its previous forecast of $…